Behavioral Program Improves Chronic Pain Outcomes in Substance Use Disorder
Behavioral management of chronic pain may improve addiction treatment outcomes.
Behavioral management of chronic pain may improve addiction treatment outcomes.
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
The FDA has announced that it is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder to include new recommendations about naloxone to the prescribing information.
Sleep disturbances are more common in patients with chronic musculoskeletal pain.
The increased risk for frequent nonmedical cannabis use among individuals with pain was elevated when comparing between surveys in the 2 time periods.
Researchers evaluated the frequency and severity of pain and fatigue in patients with psoriatic arthritis receiving tumor necrosis factor inhibitors.
Patients on hemodialysis who use opioids concurrently with a short-acting benzodiazepine are especially at risk for early death, a study found.
In order to provide national guidance addressing issues surrounding pain management practices, an expert panel was convened to provide a framework for pain practitioners and institutions.
Managing moderate or severe postoperative pain, which affects 75% of patients in the United States, remains a challenge for physicians.
The AMA called for alterations for insurers, including terminating cost-sharing and prior authorization for chronic pain and OUD medications and removing restrictions on Medicaid preferred drug lists.